↓ Skip to main content

Dove Medical Press

Clinical Utility of Fedratinib in Myelofibrosis

Overview of attention for article published in OncoTargets and therapy, August 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
15 Mendeley
Title
Clinical Utility of Fedratinib in Myelofibrosis
Published in
OncoTargets and therapy, August 2021
DOI 10.2147/ott.s267001
Pubmed ID
Authors

Julian A Waksal, Douglas Tremblay, John Mascarenhas

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 27%
Unspecified 2 13%
Other 2 13%
Lecturer > Senior Lecturer 1 7%
Student > Ph. D. Student 1 7%
Other 0 0%
Unknown 5 33%
Readers by discipline Count As %
Medicine and Dentistry 4 27%
Unspecified 2 13%
Computer Science 1 7%
Biochemistry, Genetics and Molecular Biology 1 7%
Sports and Recreations 1 7%
Other 1 7%
Unknown 5 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2021.
All research outputs
#8,065,946
of 25,655,374 outputs
Outputs from OncoTargets and therapy
#438
of 3,013 outputs
Outputs of similar age
#157,682
of 442,352 outputs
Outputs of similar age from OncoTargets and therapy
#9
of 62 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,013 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,352 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.